HOME >> BIOLOGY >> NEWS
Blood proteins tied to inflammation

A Johns Hopkins-led study shows that two proteins, C-reactive protein and albumin, are accurate predictors of heart attack or stroke in kidney dialysis patients. The research team found that high levels of C-reactive protein, a marker of inflammation, and low levels of albumin, a sign of malnutrition, had strong ties to heart disease in these patients, who are many times more likely to develop heart problems than the general population.

"Both inflammation and malnutrition play an important role in the high risk of cardiovascular disease among dialysis patients," says Josef Coresh, M.D., Ph.D., lead author of the study and associate professor of epidemiology, medicine and biostatistics at Hopkins. "Testing for these proteins will allow us to sooner identify patients at high risk, and to manage heart disease risk factors more effectively."

Results of the study are to be presented Nov. 18 at the American Heart Association's 75th annual Scientific Sessions in Chicago.

Coresh and colleagues examined data from the Choices for Healthy Outcomes in Caring for End-stage renal disease (CHOICE) Study, a Hopkins effort that followed more than 1,000 dialysis patients nationwide between October 1995 and June 1998. For this study, they collected blood samples from 810 patients who had been on dialysis for an average of four months and measured levels of C-reactive protein and albumin. They also reviewed the patients' medical records until November 2000.

During the follow-up period, the patients had a combined 278 heart events, including heart attack, bypass surgery, angioplasty, stroke, carotid endarterectomy (a procedure to remove plaque from the neck artery), peripheral vascularization (a type of angioplasty used to dilate narrowed arteries in the legs), or amputation. The risk of heart disease increased with high C-reactive protein levels and low albumin levels, even after adjusting for factors like cholesterol level, smoking status an
'"/>

Contact: Karen Blum
kblum@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
18-Nov-2002


Page: 1 2

Related biology news :

1. Blood pressure hormone may inhibit growth of lung cancer
2. Blood tests identify patients on dialysis at high risk for death from cardiovascular disease
3. Blood banking systems improving in China, more progress needed
4. Bloodworms way with copper likely provides paradigm for new materials
5. Blood markers may reflect newborns potential of contracting HIV
6. Blood stem cells carry targeted genes
7. Blood vessels trigger development of the pancreas
8. Blood vessels found to signal chain of destruction in bone diseases
9. Blood markers associated with autism and mental retardation
10. Blood test for diagnosing schizophrenia
11. Blood pressure-lowering DASH diet also reduces homocysteine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/15/2018)... ... September 14, 2018 , ... The first ever production picosecond-domain laser with a ... and purple tattoo inks - often the colors most resistant to laser removal. , ... of the American Society for Laser Medicine and Surgery, Inc. (ASLMS) investigated the safety ...
(Date:9/12/2018)... ... September 11, 2018 , ... Tennant Coatings, ... the new ChemXP™ line of high performance secondary containment coatings, designed to protect ... provide Tennant Coatings’ elite certified installers with the needed solutions to protect facility’s ...
(Date:9/7/2018)... ... September 05, 2018 , ... Following ... manufacturing facility late last year, IPS-Integrated Project Services, LLC and G-CON Manufacturing have ... cell therapies. The iCON solution provides a pre-fabricated modular cleanroom infrastructure for the ...
Breaking Biology News(10 mins):
(Date:9/22/2018)... WESTMINSTER, Colo. (PRWEB) , ... ... ... Flagship Biosciences are excited to announce a strategic venture. The synergistic combination ... pathology platform provides complimentary and comprehensive biomarker profiling to empower clinical trials ...
(Date:9/13/2018)... , ... September 13, 2018 , ... Asymmetrex’s ... think we would have gotten in medicine, if we didn’t have the means to ... to treat patients?” His answer, “Nowhere! And that is what’s holding up progress ...
(Date:9/7/2018)... SANTA CLARA, Calif. (PRWEB) , ... September 05, 2018 , ... ... sponsored by Park Systems will be held on Sept. 19, 2018. With a panel ... trends on SPM, this exciting event will reveal industry insights from experts in the ...
(Date:9/1/2018)... ... 2018 , ... Rudina Thanasi, a scientifically validated holistic energy ... treated nutraceutical supplement used in combating inflammation and autoimmune disorders. , ... as, organ-specific inflammation. The reported data is as follows: , More than ...
Breaking Biology Technology:
Cached News: